These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 2342686)
21. Imipramine-induced hyperpigmentation: a case report and review of the literature. D'Agostino ML; Risser J; Robinson-Bostom L J Cutan Pathol; 2009 Jul; 36(7):799-803. PubMed ID: 19519613 [TBL] [Abstract][Full Text] [Related]
23. Imatinib-associated hyperpigmentation, a side effect that should be recognized. Mcpherson T; Sherman V; Turner R J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):82-3. PubMed ID: 18384557 [No Abstract] [Full Text] [Related]
24. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity. Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247 [TBL] [Abstract][Full Text] [Related]
25. [Hyperpigmentation caused by amiodaron]. Lakatos A; Török L; Szücs M; Oze B Orv Hetil; 1985 Jun; 126(22):1343-5. PubMed ID: 3159995 [No Abstract] [Full Text] [Related]
26. [Treatment of acute myeloid leukemia with an intense chemotherapeutic regimen and variable reduction of the dosage for elderly patients]. Whittaker JA Clin Ter; 1982 Sep; 102(5):435-41. PubMed ID: 6960975 [No Abstract] [Full Text] [Related]
31. Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia. Dengler R; Plewan A; Münstermann U; Busch R; Eger G; Emmerich B Clin Cancer Res; 1995 Feb; 1(2):199-205. PubMed ID: 9815974 [TBL] [Abstract][Full Text] [Related]
32. [The effect of cytostatic therapy on pyruvate kinase activity in the erythrocytes of patients with acute myelocytic leukemia]. Labar B; Jusufhodzić L Lijec Vjesn; 1985 Feb; 107(2):61-3. PubMed ID: 3856722 [No Abstract] [Full Text] [Related]
33. [Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols]. del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Krsnik I; Guerra JL; Llorente L; López JC; Díaz Morfa M; Villegas A Med Clin (Barc); 1989 Apr; 92(16):601-4. PubMed ID: 2747321 [TBL] [Abstract][Full Text] [Related]
34. [Acute myeloid leukemia six years after chemotherapy of Hodgkin's disease]. Fujii H; Yashige H; Maekawa T; Horiike S Rinsho Ketsueki; 1988 Dec; 29(12):2369-74. PubMed ID: 3246723 [No Abstract] [Full Text] [Related]
35. Photo quiz. Blue-gray centrofacial hyperpigmentation. Rubegni P; de Aloe G; Maritati E; Mondillo S Am Fam Physician; 2001 Apr; 63(7):1409-10. PubMed ID: 11310653 [No Abstract] [Full Text] [Related]
36. [Hyperpigmentation and zidovudine]. Valencia ME; López Duplá JM; Lavilla P; Gil Aguado A Med Clin (Barc); 1989 Mar; 92(9):357-8. PubMed ID: 2716434 [No Abstract] [Full Text] [Related]
37. Horizontal pigmented banding of the nails in association with adriamycin chemotherapy. Morris D; Aisner J; Wiernik PH Cancer Treat Rep; 1977; 61(3):499-501. PubMed ID: 872150 [No Abstract] [Full Text] [Related]
38. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine). Lipton JH; Gospodarowicz M; Reingold S Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133 [TBL] [Abstract][Full Text] [Related]
39. [New agents in the treatment of leukemia and lymphoma]. Yamada K Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1031-40. PubMed ID: 6347079 [No Abstract] [Full Text] [Related]
40. [Ischemic hepatitis due to anthracycline-induced cardiac insufficiency in a patient with acute myelocytic leukemia (M0)]. Toi T; Sawai H; Takeda Y; Mizuta K; Tashima M; Sawada H; Okuma M Rinsho Ketsueki; 1995 Jan; 36(1):50-5. PubMed ID: 7715077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]